Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TPT1 pseudogene 12 (TPT1P12) is designated as a pseudogene related to the protein-coding gene Tumor Protein, Translationally-Controlled 1 (TPT1/TCTP), a gene involved in cell growth, proliferation, and apoptosis[1][3][5]. Pseudogenes such as TPT1P12 typically arise from duplication or retrotransposition of their progenitor gene and are generally considered non-functional due to mutations that prevent the expression of a full-length, active protein[4]. There is no evidence that TPT1P12 produces a functional protein or acts as a therapeutic target. No drugs, disease associations, or molecular interactions specific to TPT1P12 have been described in the biomedical literature or major gene/protein databases as of 2024. Note: Information found in gene databases and scientific sources focuses on TPT1 (a protein-coding gene with therapeutic/biological relevance), but TPT1P12 is a pseudogene with no established biological or therapeutic functions[1][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TPT1 pseudogene 12 (TPT1P12).